Try our beta test site

Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Patients

This study has been terminated.
(Termination due to not achieving the recruitment target because of change in the development program for QTI571 in PAH.)
Sponsor:
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )
ClinicalTrials.gov Identifier:
NCT01392469
First received: May 10, 2011
Last updated: February 20, 2017
Last verified: February 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 24, 2012
  Primary Completion Date: December 24, 2012 (Final data collection date for primary outcome measure)